ESSA Pharma Ownership 2024 | Who Owns ESSA Pharma Now?

OverviewFinancials Chart

Institutional Ownership

79.59%

Insider Ownership

2.27%

Retail Ownership

18.14%

Institutional Holders

34.00

ESSA Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BVF INC/IL	19.78%	1.29%	8,748,629	-	-	46,017,788	Jun 30, 2024
BELLEVUE GROUP AG	17.83%	0.67%	7,889,583	-	-	41,499,207	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	9.52%	1.95%	4,210,537	620,979	17.30%	22,147,425	Jun 30, 2024
MORGAN STANLEY	9.44%	0.00%	4,177,848	-700	-0.02%	21,975,480	Jun 30, 2024
PFM HEALTH SCIENCES, LP	6.70%	0.77%	2,965,442	-14,978	-0.50%	15,598,225	Jun 30, 2024
RTW INVESTMENTS, LP	5.20%	0.19%	2,298,662	-	-	12,090,962	Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.	3.33%	0.01%	1,474,165	-106,210	-6.72%	7,754,108	Jun 30, 2024
JANUS HENDERSON GROUP PLC	2.27%	0.00%	1,006,202	-169,040	-14.38%	5,192,002	Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB	1.82%	0.41%	806,054	-105,766	-11.60%	4,239,844	Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP	1.53%	0.11%	677,005	-	-	3,561,046	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	0.71%	0.01%	315,736	-52,764	-14.32%	1,660,771	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	0.57%	0.18%	252,072	377	0.15%	1,325,899	Jun 30, 2024
CIBC WORLD MARKET INC.	0.18%	0.00%	80,257	-600	-0.74%	422,000	Jun 30, 2024
D. E. SHAW & CO., INC.	0.14%	0.00%	63,481	-1,600	-2.46%	333,910	Jun 30, 2024
AMERICAN CENTURY COMPANIES INC	0.11%	0.00%	46,748	572	1.24%	245,894	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.10%	0.00%	43,595	1,100	2.59%	229,310	Jun 30, 2024
ROYAL BANK OF CANADA	0.08%	-	36,312	5,537	17.99%	191,000	Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC	0.08%	0.00%	34,465	34,465	100.00%	181,286	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.06%	-	26,858	-	-	141,273	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.02%	0.00%	10,313	10,313	100.00%	54,246	Jun 30, 2024

ESSA Pharma's largest institutional shareholder is BVF INC/IL, holding 19.78% of the company's total share outstanding, currently valued at $46.02M. The top 10 institutional shareholders own together 77.43% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SOLEUS CAPITAL MANAGEMENT, L.P.	9.52%	1.95%	4,210,537	620,979	17.30%	22,147,425	Jun 30, 2024
BVF INC/IL	19.78%	1.29%	8,748,629	-	-	46,017,788	Jun 30, 2024
PFM HEALTH SCIENCES, LP	6.70%	0.77%	2,965,442	-14,978	-0.50%	15,598,225	Jun 30, 2024
BELLEVUE GROUP AG	17.83%	0.67%	7,889,583	-	-	41,499,207	Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB	1.82%	0.41%	806,054	-105,766	-11.60%	4,239,844	Jun 30, 2024
RTW INVESTMENTS, LP	5.20%	0.19%	2,298,662	-	-	12,090,962	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	0.57%	0.18%	252,072	377	0.15%	1,325,899	Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP	1.53%	0.11%	677,005	-	-	3,561,046	Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.	3.33%	0.01%	1,474,165	-106,210	-6.72%	7,754,108	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	0.71%	0.01%	315,736	-52,764	-14.32%	1,660,771	Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC	0.08%	0.00%	34,465	34,465	100.00%	181,286	Jun 30, 2024
JANUS HENDERSON GROUP PLC	2.27%	0.00%	1,006,202	-169,040	-14.38%	5,192,002	Jun 30, 2024
MORGAN STANLEY	9.44%	0.00%	4,177,848	-700	-0.02%	21,975,480	Jun 30, 2024
CIBC WORLD MARKET INC.	0.18%	0.00%	80,257	-600	-0.74%	422,000	Jun 30, 2024
LAUREL WEALTH ADVISORS LLC	0.00%	0.00%	600	-	-	3,156	Jun 30, 2024
D. E. SHAW & CO., INC.	0.14%	0.00%	63,481	-1,600	-2.46%	333,910	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.10%	0.00%	43,595	1,100	2.59%	229,310	Jun 30, 2024
AMERICAN CENTURY COMPANIES INC	0.11%	0.00%	46,748	572	1.24%	245,894	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.02%	0.00%	10,313	10,313	100.00%	54,246	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	0.00%	6,000	-	-	31,560	Jun 30, 2024

The largest ESSA Pharma shareholder by % of total assets is SOLEUS CAPITAL MANAGEMENT, L.P.. The company owns 4.21M shares of ESSA Pharma (EPIX), representing 1.95% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SOLEUS CAPITAL MANAGEMENT, L.P.	9.52%	1.95%	4,210,537	620,979	17.30%	22,147,425	Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC	0.08%	0.00%	34,465	34,465	100.00%	181,286	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.02%	0.00%	10,313	10,313	100.00%	54,246	Jun 30, 2024
ROYAL BANK OF CANADA	0.08%	-	36,312	5,537	17.99%	191,000	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	0.00%	2,050	2,000	4000.00%	10,783	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.10%	0.00%	43,595	1,100	2.59%	229,310	Jun 30, 2024
AMERICAN CENTURY COMPANIES INC	0.11%	0.00%	46,748	572	1.24%	245,894	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	0.57%	0.18%	252,072	377	0.15%	1,325,899	Jun 30, 2024
BANK OF AMERICA CORP /DE/	-	-	8	-	-	42	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	21	-	-	110	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	48	-	-	252	Jun 30, 2024
BLACKROCK INC.	0.01%	-	5,609	-	-	29,503	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.06%	-	26,858	-	-	141,273	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.01%	-	2,500	-	-	12,900	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	0.00%	900	-	-	9,849	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	0.00%	6,000	-	-	31,560	Jun 30, 2024
LAUREL WEALTH ADVISORS LLC	0.00%	0.00%	600	-	-	3,156	Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP	1.53%	0.11%	677,005	-	-	3,561,046	Jun 30, 2024
RTW INVESTMENTS, LP	5.20%	0.19%	2,298,662	-	-	12,090,962	Jun 30, 2024
BELLEVUE GROUP AG	17.83%	0.67%	7,889,583	-	-	41,499,207	Jun 30, 2024

As of Jun 30 2024, ESSA Pharma's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 620.98K stocks of EPIX, valued at $22.15M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JANUS HENDERSON GROUP PLC	2.27%	0.00%	1,006,202	-169,040	-14.38%	5,192,002	Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.	3.33%	0.01%	1,474,165	-106,210	-6.72%	7,754,108	Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB	1.82%	0.41%	806,054	-105,766	-11.60%	4,239,844	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	0.71%	0.01%	315,736	-52,764	-14.32%	1,660,771	Jun 30, 2024
TUCKER ASSET MANAGEMENT LLC	-	-	-	-16,097	-100.00%	-	Jun 30, 2024
PFM HEALTH SCIENCES, LP	6.70%	0.77%	2,965,442	-14,978	-0.50%	15,598,225	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-14,052	-100.00%	-	Jun 30, 2024
ENTRYPOINT CAPITAL, LLC	-	-	-	-4,420	-100.00%	-	Jun 30, 2024
SIMPLEX TRADING, LLC	-	-	-	-4,329	-100.00%	-	Jun 30, 2024
UBS GROUP AG	0.00%	-	1,565	-2,061	-56.84%	8,232	Jun 30, 2024
D. E. SHAW & CO., INC.	0.14%	0.00%	63,481	-1,600	-2.46%	333,910	Jun 30, 2024
MORGAN STANLEY	9.44%	0.00%	4,177,848	-700	-0.02%	21,975,480	Jun 30, 2024
CIBC WORLD MARKET INC.	0.18%	0.00%	80,257	-600	-0.74%	422,000	Jun 30, 2024
BVF INC/IL	19.78%	1.29%	8,748,629	-	-	46,017,788	Jun 30, 2024
BELLEVUE GROUP AG	17.83%	0.67%	7,889,583	-	-	41,499,207	Jun 30, 2024
RTW INVESTMENTS, LP	5.20%	0.19%	2,298,662	-	-	12,090,962	Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP	1.53%	0.11%	677,005	-	-	3,561,046	Jun 30, 2024
LAUREL WEALTH ADVISORS LLC	0.00%	0.00%	600	-	-	3,156	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	0.00%	6,000	-	-	31,560	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	0.00%	900	-	-	9,849	Jun 30, 2024

As of Jun 30 2024, ESSA Pharma's biggest institutional seller is JANUS HENDERSON GROUP PLC. The company sold -0.17M shares of EPIX, valued at $5.19M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
KENNEDY CAPITAL MANAGEMENT LLC	0.08%	0.00%	34,465	34,465	100.00%	181,286	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.02%	0.00%	10,313	10,313	100.00%	54,246	Jun 30, 2024

ESSA Pharma's largest new institutional shareholder by number of shares is KENNEDY CAPITAL MANAGEMENT LLC, purchased 34.47K shares, valued at $181.29K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TUCKER ASSET MANAGEMENT LLC	-	-	-	-16,097	-100.00%	-	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-14,052	-100.00%	-	Jun 30, 2024
ENTRYPOINT CAPITAL, LLC	-	-	-	-4,420	-100.00%	-	Jun 30, 2024
SIMPLEX TRADING, LLC	-	-	-	-4,329	-100.00%	-	Jun 30, 2024

ESSA Pharma's largest sold out institutional shareholder by shares sold is TUCKER ASSET MANAGEMENT LLC, sold -16.10K shares, valued at -, as of undefined.

ESSA Pharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
ETFis Series Trust I	0.01%	12,885	-	-	Jan 31, 2024
FIDELITY SELECT PORTFOLIOS	0.01%	371,150	-	-	Feb 29, 2024
DRIEHAUS MUTUAL FUNDS	0.01%	51,349	-	-	Mar 28, 2024
Nushares ETF Trust	0.00%	29,624	-	-	Jan 31, 2024
VANGUARD HORIZON FUNDS	0.00%	59,917	-	-	Mar 31, 2024
JANUS INVESTMENT FUND	0.00%	783,841	-	-	Dec 31, 2023
ALPS ETF Trust	0.00%	27,865	-	-	Feb 29, 2024
Brinker Capital Destinations Trust	0.00%	58,082	-	-	Feb 29, 2024
FIDELITY COVINGTON TRUST	0.00%	10,426	-	-	Jan 31, 2024
PENN SERIES FUNDS INC	0.00%	16,385	-	-	Mar 28, 2024
MUTUAL FUND SERIES TRUST	0.00%	1,561,251	-	-	Mar 31, 2024
OLD WESTBURY FUNDS INC	0.00%	44,648	-	-	Jan 31, 2024
VANGUARD WORLD FUND	0.00%	73,307	-	-	Feb 29, 2024
RBB FUND, INC.	0.00%	24,520	-	-	Feb 29, 2024
AMERICAN CENTURY ETF TRUST	0.00%	25,101	18,219	264.73%	Feb 29, 2024
ARTISAN PARTNERS FUNDS INC	0.00%	197,335	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	26,858	-	-	Feb 29, 2024
SPDR INDEX SHARES FUNDS	0.00%	24,632	-	-	Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS	0.00%	562	-	-	Mar 31, 2024
NORTHERN FUNDS	0.00%	4,323	-	-	Mar 28, 2024
FundVantage Trust	0.00%	195	-	-	Mar 28, 2024
Blackstone Alternative Investment Funds	0.00%	800	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	1,866	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	32,540	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	180	-	-	Jan 31, 2024

ESSA Pharma's largest mutual fund holder by % of total assets is "ETFis Series Trust I", owning 12.88K shares, compromising 0.01% of its total assets.

ESSA Pharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	34	-8.11%
31 Mar, 24	37	5.71%
31 Dec, 23	35	-10.26%
30 Sep, 23	39	-9.30%
30 Jun, 23	43	7.50%
31 Mar, 23	40	-14.89%
31 Dec, 22	47	-7.84%
30 Sep, 22	51	-8.93%
30 Jun, 22	56	-18.84%
31 Mar, 22	69	16.95%
31 Dec, 21	59	-20.27%
30 Sep, 21	74	-3.90%
30 Jun, 21	77	14.93%
31 Mar, 21	67	81.08%
31 Dec, 20	37	15.63%
30 Sep, 20	32	77.78%
30 Jun, 20	18	28.57%
31 Mar, 20	14	-17.65%
31 Dec, 19	17	41.67%
30 Sep, 19	12	71.43%
30 Jun, 19	7	-
31 Mar, 19	7	-
31 Dec, 18	7	-
30 Sep, 18	7	-
30 Jun, 18	7	-

As of 30 Jun 24, 34 institutions are holding ESSA Pharma's shares, representing a decrease of -8.11% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	35,208,390	0.49%
31 Mar, 24	35,037,057	0.76%
31 Dec, 23	34,772,388	3.89%
30 Sep, 23	33,469,182	0.60%
30 Jun, 23	33,269,455	0.54%
31 Mar, 23	33,092,172	-0.83%
31 Dec, 22	33,368,838	-1.26%
30 Sep, 22	33,793,965	-10.54%
30 Jun, 22	37,774,137	1.55%
31 Mar, 22	37,197,582	-0.37%
31 Dec, 21	37,334,765	0.43%
30 Sep, 21	37,173,985	8.93%
30 Jun, 21	34,126,760	10.78%
31 Mar, 21	30,804,832	33.42%
31 Dec, 20	23,088,411	13.80%
30 Sep, 20	20,288,041	44.53%
30 Jun, 20	14,037,155	-1.34%
31 Mar, 20	14,228,404	2.30%
31 Dec, 19	13,908,596	13.60%
30 Sep, 19	12,243,635	123.37%
30 Jun, 19	5,481,234	43.16%
31 Mar, 19	3,828,813	0.00%
31 Dec, 18	3,828,750	0.10%
30 Sep, 18	3,825,113	39.11%
30 Jun, 18	2,749,682	-

ESSA Pharma (EPIX) has 35.21M shares outstanding as of 30 Jun 24, up 0.49% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	79.59%	1.26%
31 Mar, 24	79.40%	1.28%
31 Dec, 23	78.80%	1.37%
30 Sep, 23	75.91%	1.33%
30 Jun, 23	75.45%	1.34%
31 Mar, 23	75.05%	1.31%
31 Dec, 22	75.71%	1.29%
30 Sep, 22	76.74%	1.04%
30 Jun, 22	85.73%	1.20%
31 Mar, 22	84.48%	1.17%
31 Dec, 21	84.87%	1.03%
30 Sep, 21	90.63%	1.31%
30 Jun, 21	83.20%	1.17%
31 Mar, 21	84.43%	1.76%
31 Dec, 20	69.24%	1.26%
30 Sep, 20	74.22%	1.63%
30 Jun, 20	67.41%	1.44%
31 Mar, 20	68.34%	1.52%
31 Dec, 19	66.99%	0.96%
30 Sep, 19	83.49%	5.98%
30 Jun, 19	37.38%	5.48%
31 Mar, 19	26.11%	3.83%
31 Dec, 18	26.11%	3.84%
30 Sep, 18	26.08%	7.42%
30 Jun, 18	18.75%	-

As of 30 Jun 24, ESSA Pharma is held by 79.59% institutional shareholders, representing a 1.26% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	8	-33.33%
31 Mar, 24	12	-20.00%
31 Dec, 23	15	25.00%
30 Sep, 23	12	20.00%
30 Jun, 23	10	-41.18%
31 Mar, 23	17	-10.53%
31 Dec, 22	19	-17.39%
30 Sep, 22	23	35.29%
30 Jun, 22	17	-59.52%
31 Mar, 22	42	35.48%
31 Dec, 21	31	-27.91%
30 Sep, 21	43	7.50%
30 Jun, 21	40	-27.27%
31 Mar, 21	55	161.90%
31 Dec, 20	21	-12.50%
30 Sep, 20	24	200.00%
30 Jun, 20	8	100.00%
31 Mar, 20	4	-33.33%
31 Dec, 19	6	-40.00%
30 Sep, 19	10	400.00%
30 Jun, 19	2	-
31 Mar, 19	2	-33.33%
31 Dec, 18	3	-25.00%
30 Sep, 18	4	-42.86%
30 Jun, 18	7	-

8 institutional shareholders have increased their position in EPIX stock as of 30 Jun 24 compared to 12 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	11	10.00%
31 Mar, 24	10	66.67%
31 Dec, 23	6	-40.00%
30 Sep, 23	10	-16.67%
30 Jun, 23	12	50.00%
31 Mar, 23	8	-52.94%
31 Dec, 22	17	21.43%
30 Sep, 22	14	-33.33%
30 Jun, 22	21	50.00%
31 Mar, 22	14	-26.32%
31 Dec, 21	19	-
30 Sep, 21	19	-9.52%
30 Jun, 21	21	162.50%
31 Mar, 21	8	-11.11%
31 Dec, 20	9	125.00%
30 Sep, 20	4	-
30 Jun, 20	4	-
31 Mar, 20	4	300.00%
31 Dec, 19	1	-
30 Sep, 19	-	-100.00%
30 Jun, 19	1	-
31 Mar, 19	-	-100.00%
31 Dec, 18	1	-
30 Sep, 18	1	-
30 Jun, 18	-	-

11 institutional shareholders have reduced their position in EPIX stock as of 30 Jun 24 compared to 10 in the previous quarter (a 10.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	34	-8.11%	35,208,390	0.49%	79.59%	1.26%	8	-33.33%	11	10.00%
31 Mar, 24	37	5.71%	35,037,057	0.76%	79.40%	1.28%	12	-20.00%	10	66.67%
31 Dec, 23	35	-10.26%	34,772,388	3.89%	78.80%	1.37%	15	25.00%	6	-40.00%
30 Sep, 23	39	-9.30%	33,469,182	0.60%	75.91%	1.33%	12	20.00%	10	-16.67%
30 Jun, 23	43	7.50%	33,269,455	0.54%	75.45%	1.34%	10	-41.18%	12	50.00%
31 Mar, 23	40	-14.89%	33,092,172	-0.83%	75.05%	1.31%	17	-10.53%	8	-52.94%
31 Dec, 22	47	-7.84%	33,368,838	-1.26%	75.71%	1.29%	19	-17.39%	17	21.43%
30 Sep, 22	51	-8.93%	33,793,965	-10.54%	76.74%	1.04%	23	35.29%	14	-33.33%
30 Jun, 22	56	-18.84%	37,774,137	1.55%	85.73%	1.20%	17	-59.52%	21	50.00%
31 Mar, 22	69	16.95%	37,197,582	-0.37%	84.48%	1.17%	42	35.48%	14	-26.32%
31 Dec, 21	59	-20.27%	37,334,765	0.43%	84.87%	1.03%	31	-27.91%	19	-
30 Sep, 21	74	-3.90%	37,173,985	8.93%	90.63%	1.31%	43	7.50%	19	-9.52%
30 Jun, 21	77	14.93%	34,126,760	10.78%	83.20%	1.17%	40	-27.27%	21	162.50%
31 Mar, 21	67	81.08%	30,804,832	33.42%	84.43%	1.76%	55	161.90%	8	-11.11%
31 Dec, 20	37	15.63%	23,088,411	13.80%	69.24%	1.26%	21	-12.50%	9	125.00%
30 Sep, 20	32	77.78%	20,288,041	44.53%	74.22%	1.63%	24	200.00%	4	-
30 Jun, 20	18	28.57%	14,037,155	-1.34%	67.41%	1.44%	8	100.00%	4	-
31 Mar, 20	14	-17.65%	14,228,404	2.30%	68.34%	1.52%	4	-33.33%	4	300.00%
31 Dec, 19	17	41.67%	13,908,596	13.60%	66.99%	0.96%	6	-40.00%	1	-
30 Sep, 19	12	71.43%	12,243,635	123.37%	83.49%	5.98%	10	400.00%	-	-100.00%
30 Jun, 19	7	-	5,481,234	43.16%	37.38%	5.48%	2	-	1	-
31 Mar, 19	7	-	3,828,813	0.00%	26.11%	3.83%	2	-33.33%	-	-100.00%
31 Dec, 18	7	-	3,828,750	0.10%	26.11%	3.84%	3	-25.00%	1	-
30 Sep, 18	7	-	3,825,113	39.11%	26.08%	7.42%	4	-42.86%	1	-
30 Jun, 18	7	-	2,749,682	-	18.75%	-	7	-	-	-

ESSA Pharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 06, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$6.95	$4.82K	11,246
Apr 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$7.94	$5.51K	11,940
Mar 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$8.98	$6.23K	12,634

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 06, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$6.95	$4.82K	11,246
Apr 25, 2024	Glickman Richard M	director	-	M-Exempt	Sell	3,750	$4.90	$18.38K	-
Apr 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$7.94	$5.51K	11,940
Mar 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$8.98	$6.23K	12,634
Feb 07, 2024	Virsik Peter	officer	Chief Operating Officer	M-Exempt	Sell	72,782	$3.23	$235.09K	895,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 06, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$6.95	$4.82K	11,246
Apr 25, 2024	Glickman Richard M	director	-	M-Exempt	Buy	3,750	$4.90	$18.38K	43,240
Apr 25, 2024	Glickman Richard M	director	-	M-Exempt	Sell	3,750	$4.90	$18.38K	-
Apr 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$7.94	$5.51K	11,940
Mar 28, 2024	ZWEIFACH SANFORD S	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Thorell Marella	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Sollis Gary	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Requadt Scott	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Merendino Lauren	director	-	A-Award	Buy	25,000	$9.04	$226.00K	25,000
Mar 28, 2024	Martin John Alexander	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Kantoff Philip W.	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Glickman Richard M	director	-	A-Award	Buy	70,000	$9.04	$632.80K	70,000
Mar 28, 2024	BERGER FRANKLIN M	director	-	A-Award	Buy	50,000	$9.04	$452.00K	50,000
Mar 28, 2024	Wood David S.	officer	Chief Financial Officer	A-Award	Buy	110,000	$9.04	$994.40K	110,000
Mar 28, 2024	Virsik Peter	officer	Chief Operating Officer	A-Award	Buy	110,000	$9.04	$994.40K	110,000
Mar 28, 2024	Parkinson David Ross	director, officer	Chief Executive Officer	A-Award	Buy	350,000	$9.04	$3.16M	350,000
Mar 28, 2024	Cesano Alessandra	officer	Chief Medical Officer	A-Award	Buy	200,000	$9.04	$1.81M	200,000
Mar 05, 2024	Virsik Peter	officer	Chief Operating Officer	S-Sale	Sell	694	$8.98	$6.23K	12,634
Feb 07, 2024	Virsik Peter	officer	Chief Operating Officer	M-Exempt	Sell	72,782	$3.23	$235.09K	895,000
Feb 07, 2024	Virsik Peter	officer	Chief Operating Officer	M-Exempt	Buy	72,782	$3.23	$235.09K	86,110

The last insider sell of ESSA Pharma's stock was made by Virsik Peter on May 06 2024, selling 694 shares at $6.95 per share (valued at $4.82K).

ESSA Pharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	1	3	33.33%
Q1 2024	16	9	177.78%
Q4 2023	5	14	35.71%
Q2 2023	-	1	-
Q1 2023	-	8	-
Q4 2022	5	15	33.33%
Q3 2022	5	4	125.00%
Q2 2022	12	2	600.00%
Q1 2022	-	7	-
Q3 2021	1	1	100.00%
Q1 2021	1	-	-
Q4 2020	25	13	192.31%
Q3 2009	-	1	-
Q2 2009	4	1	400.00%
Q1 2009	3	6	50.00%
Q4 2008	2	2	100.00%
Q2 2008	4	-	-
Q1 2008	4	-	-
Q4 2007	1	-	-
Q2 2007	4	-	-

1 total buy trades, and 3 total sell trades (buy/sell ratio of 0.33%) were made by ESSA Pharma's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	2	-
Q1 2024	-	6	-
Q4 2023	4	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	5	7	71.43%
Q3 2022	5	-	-
Q2 2022	1	2	50.00%
Q1 2022	-	-	-
Q3 2021	1	-	-
Q1 2021	1	-	-
Q4 2020	-	-	-
Q3 2009	-	-	-
Q2 2009	-	-	-
Q1 2009	-	-	-
Q4 2008	-	-	-
Q2 2008	-	-	-
Q1 2008	-	-	-
Q4 2007	-	-	-
Q2 2007	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of ESSA Pharma's stocks.

ESSA Pharma Peer Ownership

Ticker	Company
SPRO	Spero Therapeutics, Inc.
SMMT	Summit Therapeutics Inc.
CYTO	Altamira Therapeutics Ltd.
AGLE	Spyre Therapeutics, Inc.
ATXI	Avenue Therapeutics, Inc.

EPIX Ownership FAQ

Who Owns ESSA Pharma?

ESSA Pharma is owned by institutional shareholders (79.59%), insiders (2.27%), and public (18.14%). The largest institutional shareholder of ESSA Pharma is BVF INC/IL (19.78% of total shares) and the top mutual fund owner is ETFis Series Trust I (0.01% of total shares).

Who are the major institutional shareholders of ESSA Pharma?

ESSA Pharma's major institutional shareholders are BVF INC/IL, BELLEVUE GROUP AG, SOLEUS CAPITAL MANAGEMENT, L.P., MORGAN STANLEY, and PFM HEALTH SCIENCES, LP. The top five shareholders own together 63.28% of the company's share outstanding.

How many ESSA Pharma shareholders are there?

As of Jun 2024, there are 34 institutional shareholders of ESSA Pharma.

What percentage of ESSA Pharma is owned by BVF INC/IL?

BVF INC/IL owns 8.75M shares of ESSA Pharma, representing 19.78% of the company's total shares outstanding, valued at $46.02M (as of Jun 2024).

What percentage of ESSA Pharma is owned by BELLEVUE GROUP AG?

As of Jun 2024, BELLEVUE GROUP AG holds 7.89M shares of ESSA Pharma (EPIX), compromising 17.83% of the company, valued at $41.5M.

What percentage of ESSA Pharma is owned by SOLEUS CAPITAL MANAGEMENT, L.P?

SOLEUS CAPITAL MANAGEMENT, L.P is the third largest holder of ESSA Pharma. The company owns 4.21M of the company's shares outstanding (worth $22.15M).